Seven Sons, Ltd.
IsraelFDA applicant, unverified
- Devices
- 1
What Seven Sons, Ltd. makes
Seven Sons, Ltd. manufactures the Stent Positioning Assistance System (SPAS), a device designed to aid in the precise placement of stents during medical procedures.
The SPAS is classified as a Class II medical device and is listed under the FDA’s 510(k) premarket notification process. The company is based in the United States.
Catalogue
Stent Positioning Assistance System (SPAS) Ref K221917
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Seven Sons, Ltd. have in the registry?
The registry currently lists 1 device for Seven Sons, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Seven Sons, Ltd.'s devices?
Among its 1 most recently registered device, Seven Sons, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Seven Sons, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Seven Sons, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Seven Sons, Ltd. in the registry?
The most recently registered devices listed for Seven Sons, Ltd. include Stent Positioning Assistance System (SPAS).